C5a Receptor (CD88) Blockade Protects against MPO-ANCA GN
Hong Xiao(Fujian Medical University), J. Charles Jennette(University of North Carolina at Chapel Hill), Mark E.T. Penfold(ChemoCentryx (United States)), Juan C. Jaén(ChemoCentryx (United States)), Lisa Seitz(ChemoCentryx (United States)), Trageen Baumgart(ChemoCentryx (United States)), Lin Gan(Zhejiang Chinese Medical University), Jay P. Powers(ChemoCentryx (United States)), Thomas J. Schall(ChemoCentryx (United States)), Ronald J. Falk(University of North Carolina at Chapel Hill), Peiqi Hu(University of British Columbia), Craig Gérard(Boston Children's Hospital), Daniel J. Dairaghi(Molecular Medicine Research Institute), Bao Lu(University of Rochester), Norma P. Gerard(Harvard University), Yu Wang(Sichuan University), Linda Ertl(ChemoCentryx (United States))
Cited by 355
Related Papers
Identification of a major co-receptor for primary isolates of HIV-1
|Nature|1996|3.7k
A new class of membrane-bound chemokine with a CX3C motif
|Nature|1997|2k
Absence of Monocyte Chemoattractant Protein-1 Reduces Atherosclerosis in Low Density Lipoprotein Receptor–Deficient Mice
|Molecular Cell|1998|1.6k